Is Royal Jelly Skin Randomized Trial safe?

Updated July 2026

Quick Answer

Royal Jelly Skin Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: A diminished ovarian reserve (DOR) refers to a reduction in the number of recruitable follicles in the ovaries or a decline in oocyte quality, leading to decreased gamete production and reduced fertility.

Key Takeaways

  • 01A diminished ovarian reserve (DOR) refers to a reduction in the number of recruitable follicles in the ovaries or a decline in oocyte quality, leading to decreased gamete production and reduced fertility. [Pi Xiangyou (2026)]
  • 02In China, due to delayed childbearing, the 2-child policy, and social environmental factors, the proportion of patients with DOR is increasing, accounting for 10% of infertile women.In recent years, the prevalence of infertility has continually increased from 12% in 2007 to 18% in 2020 in China. [Pi Xiangyou (2026)]
  • 03However, with advances in assisted reproductive technology, the success rate of infertility treatment has increased from 26% in 1990 to 40% to 60% in 2020. [Pi Xiangyou (2026)]
  • 04Additionally, MRJPs elevate the uterine and ovarian indices and promote follicular development. [Pi Xiangyou (2026)]
The current Migaku evidence database contains 1 reusable source document for Royal Jelly Skin Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - A diminished ovarian reserve (DOR) refers to a reduction in the number of recruitable follicles in the ovaries or a decline in oocyte quality, leading to decreased gamete production and reduced fertility. [Pi Xiangyou (2026); evidence level 4] - In China, due to delayed childbearing, the 2-child policy, and social environmental factors, the proportion of patients with DOR is increasing, accounting for 10% of infertile women.In recent years, the prevalence of infertility has continually increased from 12% in 2007 to 18% in 2020 in China. [Pi Xiangyou (2026); evidence level 4] - However, with advances in assisted reproductive technology, the success rate of infertility treatment has increased from 26% in 1990 to 40% to 60% in 2020. [Pi Xiangyou (2026); evidence level 4] - Additionally, MRJPs elevate the uterine and ovarian indices and promote follicular development. [Pi Xiangyou (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Spontaneous pregnancy in a woman with diminished ovarian reserve following dietary supplementation with major royal jelly proteins: A case report